Carfilzomib
The present invention relates to a process for the purification of Carfiizomib of Formula Ϊ that reduces the level of an acetaniide impurity of Formula II preferably below 0.10 wt%. Formula I Formula II.
A Process For Purification of Carfilzomib
Cabri W
2015
Abstract
The present invention relates to a process for the purification of Carfiizomib of Formula Ϊ that reduces the level of an acetaniide impurity of Formula II preferably below 0.10 wt%. Formula I Formula II.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.